1. The Role of Pharmacy Refill Measures in Assessing Adherence and Predicting HIV Disease Markers in Youth with Perinatally-Acquired HIV (PHIV)
- Author
-
Cenk, Yildirim, Patricia A, Garvie, Miriam, Chernoff, Megan L, Wilkins, E Doyle, Patton, Paige L, Williams, Sharon L, Nichols, and Elizabeth, Willen
- Subjects
Adult ,Male ,medicine.medical_specialty ,Adolescent ,Social Psychology ,Disease Response ,Anti-HIV Agents ,Human immunodeficiency virus (HIV) ,HIV Infections ,medicine.disease_cause ,Logistic regression ,Article ,Medication Adherence ,Young Adult ,03 medical and health sciences ,0302 clinical medicine ,Antiretroviral Therapy, Highly Active ,Internal medicine ,medicine ,Humans ,030212 general & internal medicine ,Pharmacy refill ,Pharmacies ,030505 public health ,Recall ,business.industry ,Public health ,Public Health, Environmental and Occupational Health ,Patient Acceptance of Health Care ,Viral Load ,Infectious Disease Transmission, Vertical ,Health psychology ,Outcome and Process Assessment, Health Care ,Infectious Diseases ,Pharmaceutical Services ,HIV-1 ,Female ,Self Report ,0305 other medical science ,business ,Viral load - Abstract
Antiretroviral (ARV) adherence is critical in monitoring disease response in youth with perinatally-acquired HIV (PHIV). We used pharmacy refill (PR) information for PHIV youth from the PHACS Memory Sub-study to calculate medication availability over 2, 4, and 6 months. PR, a proxy of adherence, was compared with self-reported 7-day adherence in predicting suppressed viral load (SVL
- Published
- 2019
- Full Text
- View/download PDF